NCT02779088 is a NA clinical trial of exercise and nutrition in Sarcopenia, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT02779088?

NCT02779088 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT02779088?

Interventions in NCT02779088: exercise and nutrition.

What condition does NCT02779088 study?

NCT02779088 studies Sarcopenia.

Is NCT02779088 still recruiting?

NCT02779088 is currently completed. Last updated 6 October 2020.

Last reviewed 2020-10-06 · How we verify

NCT02779088

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Physical Fitness Cohort Study in the Community-dwelling Elderly in the WanHwa Area.

Completed NA Last updated 6 October 2020

What this trial tests

NA trial testing exercise and nutrition in Sarcopenia in 66 participants. Completed in 22 January 2019.

Timeline

24 April 2016

Primary endpoint
22 January 2019

22 January 2019

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	66
Start date	24 April 2016
Primary completion	22 January 2019
Estimated completion	22 January 2019
Sites	1 location across Taiwan

Drugs / interventions tested

exercise and nutrition

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

National Taiwan University Hospital

Who can join

Adults 65 to 100, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study are to establish the cohort of elder population based on parameters of health-related fitness, body compositions, blood biochemistry, blood biomarker, balance, quality of life, and musculoskeletal ultrasonography; and to evaluate the association between fitness parameters and disease incidence with those data.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention.
Chang KV, Wu WT, Chen YH, Chen LR, et al · · 2023 · cited 45× · PMID 38032288 · DOI 10.18632/aging.205254
Effectiveness of early versus delayed exercise and nutritional intervention on segmental body composition of sarcopenic elders - A randomized controlled trial.
Chang KV, Wu WT, Huang KC, Han DS. · · 2021 · cited 28× · PMID 32723507 · DOI 10.1016/j.clnu.2020.06.037
Novel metabolic and lipidomic biomarkers of sarcopenia.
Hsu WH, Wang SY, Chao YM, Chang KV, et al · · 2024 · cited 22× · PMID 39169398 · DOI 10.1002/jcsm.13567
Expression of Telomeric Repeat-Containing RNA Decreases in Sarcopenia and Increases after Exercise and Nutrition Intervention.
Chang KV, Chen YC, Wu WT, Shen HJ, et al · · 2020 · cited 19× · PMID 33302352 · DOI 10.3390/nu12123766
Telomeric repeat-containing RNA increases in aged human cells.
Hsieh YH, Tai CH, Yeh MT, Chen YC, et al · · 2025 · cited 6× · PMID 40637232 · DOI 10.1093/nar/gkaf597
Plasma levels of adrenaline, noradrenaline, dopamine, serotonin, and cortisol in sarcopenia: comparison with non-sarcopenic individuals and the impact of resistance exercise and nutrition interventions.
Chang KV, Wu WT, Chen YH, Chen LR, et al · · 2025 · PMID 41297911 · DOI 10.1080/15502783.2025.2586555

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02779088 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 6 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02779088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing